The human insulin analog aspart can induce insullin allergy [2]

Diabetes Care

Volumn 27, Issue 8, 2004, Pages 2084-2085

  Jixiong, Xu ^a   Jianying, Liu ^a   Yulan, Chang ^a   Huixian, Chen ^a  

^a Department of Endocrinology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN LISPRO; ISOPHANE INSULIN; NOVOLIN 30R; NOVOLIN R; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; DISSOCIATION; FEMALE; HUMAN; INSULIN ALLERGY; LETTER; MALE; MEDICATION ERROR; NON INSULIN DEPENDENT DIABETES MELLITUS; PRICK TEST; PRURITUS; RASH; SKIN ALLERGY; URTICARIA;

EID: 3342998330     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.8.2084-a     Document Type: Letter

References (5)

1. Setter SM, Corbett CF, Campbell RK, White JR: Insulin aspart: a new rapid-acting insulin analog. Ann Pharmacother 34:1423-1431, 2000
2. Ottensen JL, Nilsson P, Jami J, Weilguny D, Duhrkop M, Bucchini D, Havelund S, Fogh JM: The potential immunogenicity of human insulin and insulin analogues evaluated in transgenic mouse model. Diabetologia 37:1178-1185, 1994
3. Yasuda H, Nagata M, Moriyama H, Fujihira K, Kotani R, Yamada K, Ueda H, Yokono K: Human insulin analog insulin aspart does not cause insulin allergy (Letter). Diabetes Care 24:2008-2009, 2001
4. Airaghi L, Lorini M, Tedeschi A: The insulin analog aspart: a safe alternative in insulin allergy (Letter). Diabetes Care 24:2000, 2001
5. Takata H, Kumon Y, Osaki F, Kumagai C, Arii K, Ikeda Y, Suehiro T, Hashimoto K: The human insulin analogue aspart is not the almighty solution for insulin allergy (Letter). Diabetes Care 26:253-254, 2003